On Tuesday, Acrivon Therapeutics Inc (NASDAQ: ACRV) was -5.26% drop from the session before settling in for the closing price of $2.09. A 52-week range for ACRV has been $1.05 – $8.74.
Healthcare Sector giant saw their annual sales slid by -74.96% over the last five years. When this article was written, the company’s average yearly earnings per share was at 6.77%. With a float of $22.31 million, this company’s outstanding shares have now reached $31.45 million.
The firm has a total of 78 workers. Let’s measure their productivity.
Acrivon Therapeutics Inc (ACRV) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Acrivon Therapeutics Inc stocks. The insider ownership of Acrivon Therapeutics Inc is 29.07%, while institutional ownership is 48.63%. The most recent insider transaction that took place on Apr 30 ’25, was worth 617,412. In this transaction 10% Owner of this company sold 437,881 shares at a rate of $1.41, taking the stock ownership to the 3,403,025 shares. Before that another transaction happened on May 01 ’25, when Company’s 10% Owner sold 298,886 for $1.34, making the entire transaction worth $400,507. This insider now owns 3,104,139 shares in total.
Acrivon Therapeutics Inc (ACRV) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.59 earnings per share (EPS) during the time that was better than consensus figure (set at -0.59) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.57 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.77% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.18% during the next five years compared to -74.96% drop over the previous five years of trading.
Acrivon Therapeutics Inc (NASDAQ: ACRV) Trading Performance Indicators
You can see what Acrivon Therapeutics Inc (ACRV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.25, a number that is poised to hit -0.59 in the next quarter and is forecasted to reach -2.15 in one year’s time.
Technical Analysis of Acrivon Therapeutics Inc (ACRV)
Analysing the last 5-days average volume posted by the [Acrivon Therapeutics Inc, ACRV], we can find that recorded value of 0.39 million was lower than the volume posted last year of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 74.56%.
During the past 100 days, Acrivon Therapeutics Inc’s (ACRV) raw stochastic average was set at 54.61%, which indicates a significant decrease from 60.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.15 in the past 14 days, which was higher than the 0.12 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.66, while its 200-day Moving Average is $2.50. Now, the first resistance to watch is $2.12. This is followed by the second major resistance level at $2.25. The third major resistance level sits at $2.33. If the price goes on to break the first support level at $1.90, it is likely to go to the next support level at $1.82. Should the price break the second support level, the third support level stands at $1.69.
Acrivon Therapeutics Inc (NASDAQ: ACRV) Key Stats
There are 31,456K outstanding shares of the company, which has a market capitalization of 62.28 million. As of now, sales total 0 K while income totals -80,560 K. Its latest quarter income was 0 K while its last quarter net income were -21,010 K.
